TACSTD2 and cervical carcinoma: Recent studies have demonstrated that an involvement of TROP2 in MAPK signaling pathway, so we hypothesized that the posphorylation of ERK1/2 may also contribute to the changes of cell cycle mediated by TROP2 in cervical cancer.